Peter McKenna retweetledi

Great news! Our spin-out company Re-Vana Therapeutics @TxVana, has secured a landmark $1 billion pharma deal that places #NorthernIreland at the forefront of cutting-edge global #MedicalInnovation.
The major collaboration with pharmaceutical leader Boehringer Ingelheim @boehringerus, will see the companies jointly develop new long-acting treatments for eye disease, tackling conditions that lead to vision loss.
“This landmark deal demonstrates the global impact of Queen’s research and the strength of Northern Ireland’s innovation ecosystem, highlighting the key role Queen’s plays in driving #innovation and enhancing the local economy.
“Through @QubisLtd, the University’s commercial arm, we have helped create more than 100 tech spinouts, generating nearly £400 million in revenue and we are ranked second in the UK for entrepreneurial impact. Re-Vana Therapeutics success is a shining example of how Northern Ireland innovation, rooted at Queen’s, is helping to transform lives on a global scale.” (Professor Sir Ian Greer, @QUBVChancellor)
Find out more: ow.ly/6GzK50WvWpl
#LoveQUB | #LoveQUBResearch | #OcularDrugDelivery | #OcularTherapeutics | @NIOgov


English


























